Coronaviruses are important human and animal pathogens. To date the novel COVID-19 coronavirus is rapidly spreading worldwide and subsequently threatening health of billions of humans. Clinical studies have shown that most COVID-19 patients suffer from the lung infection. Although chest CT has been shown to be an effective imaging technique for lung-related disease diagnosis, chest Xray is more widely available due to its faster imaging time and considerably lower cost than CT.
Introduction
Recently, the rapid spread of coronavirus disease (named COVID-19) has caused panic worldwide since December 2019. The rapid escalation of COVID-19 pandemic-with hundreds of deaths and thousands of infections emerging in many areas every day-is presenting great challenges for stopping the virus [1, 2] .
Currently, viral nucleic acid detection using real-time polymerase chain reaction (RT-PCR) is the accepted standard diagnostic method. However, many hyper-endemic regions or countries are not able to provide the sufficient RT-PCR testing for tens of thousands of suspected patients. To address the lack of reagents, efforts have been made to detect COVID-19 from CT images. Fang et al. [6] reported the high sensitivity (up to 98%) of chest CT for COVID-19 screening in a series of 51 patients. To speed up the screening, Ophir et al. [8] employed the deep learning technology to detect COVID-19 on CT images. Shi et al. [13] collected a large-scale COVID-19 CT dataset and developed an machine learning based method for COVID-19 screening. A drawback of CT imaging is that typically it takes considerably more time than X-ray imaging. Besides, sufficient high-quality CT scanners may not be available in many under-developed regions, making timely COVID-19 screening become impossible. In contrast, X-rays are the most common and widely available diagnostic imaging technique, playing a crucial role in clinical care and epidemiological studies [7, 4] . Most ambulatory care facilities, even in rural regions, have deployed X-ray units as a basic diagnostic imaging. Besides, real-time imaging of X-rays would significantly speed up the disease screening.
In view of these advantages, we aim to develop a deep learning-based model that can detect COVID-19 based on chest X-ray images with sufficiently high sensitivity, enabling fast and reliable screening. The detected suspected COVID-19 patients will then be reported for the next clinical viral nucleic acid detection. Detecting COVID-19 using chest X-ray with high sensitivity is very challenging, not only due to the ribs overlying soft tissue and low contrast but also because of the limited availability of a large number of annotated data. This is particularly true for deep learning based approaches as deep learning is notoriously being data hungry. To tackle this problem, we collect additional pneumonia images from the public ChestX-ray14 dataset [14] as non-COVID-19 cases. To address the data imbalance problem existing between COVID-19 and non-COVID-19 cases, we propose a X-raybased COVID-19 screening model, inspired by [11] , to promote the imbalance binary classification task through the anomaly detection task.
Methods
We propose a deep-learning model to identify COVID-19 from non-COVID-19 cases. As shown in Figure 1 , the model is composed of three components, namely, a backbone network, a classification head, and an anomaly detection head. Given an input chest X-ray image x, we employ the backbone network to extract its high-level features, which are then input into the classification head and anomaly detection head, respectively. The classification head generates a classification score p cls , and the anomaly detection head generates a scalar anomaly score p ano . Subsequently, we calculate another scalar score µ as a reference by randomly selecting l normal X-ray images and calculating the mean of l anomaly scores of them. Finally, we optimize the model via minimizing the binary cross entropy loss for classification and the deviation loss for anomaly detection, aiming to assign statistically significantly larger classification scores and anomaly scores to X-ray images with COVID-19 than those assigned to normal controls.
Backbone network. We use the 18-layer residual convolutional neural network [10] pretrained on the ImageNet dataset [5] as the backbone network. In Figure. 1(a), the rectangles with different colors represent the five stages of the backbone network. Large covolutions with 7 × 7 kernels and a stride of 2 are used in the first stage, followed by a 3 × 3 max-pooling layer with a stride of 2. Next, each stage is composed of two residual blocks, each containing two convolutional layers and one skip connection. After the layer-by-layer convolutional operations, the input image can be encoded as a feature map with a output stride of 5.
Classification head. To classify the input image, we design the classification head and supplement it at the end of backbone network. We add a new classification convolutional layer with a stride of 2 and a multi-layer perception, which contains a 100-neuron hidden layer, a one-neuron output layer, and the sigmoid activation. To optimize the classification head, we choose the binary cross-entropy loss as
where y represents the ground truth label, i.e., y = 0 means that the input is a non-COVID-19 case and y = 1 means a COVID-19 case. Anomaly detection head. In the meantime, we also supplement the backbone network with the anomaly detection head, which has the same architecture with the classification head. Differently, this head generates the scalar anomaly scores and, accordingly, detects anomaly images (i.e., COVID-19 cases). To guide the learning of anomaly detection branch, we randomly sample l normal data from a Gaussian distribution, i.e., r 1 , r 2 , ..., r l ∼ N (µ, σ 2 ), and define the reference score as µ R = 1 l l i=1 r i . Following [11] , we set µ = 0 and σ = 1 for this work. With the obtained anomaly score and reference score, we employ the following contrastive loss [9, 3] to optimize the COVID-19 score generator
where σ R is the standard deviation of the anomaly scores of randomly selected l normal data, and margin is the Zscore confidence interval parameter. For this work, margin is empirically set to 5.
Training algorithm. In the training stage, we use the standard Stochastic gradient descent (SGD) algorithm with a batch size of 128 as the optimizer. We set the max epochs to 500 and set the learning rate to 10 −4 , which is linearly decayed. We resize each training images to a fixed size of 512 × 512 pixels. To alleviate the overfitting of our model on the training data, we use the data argumentation strategies, including randomly cropping 448 × 448 patches from resized images, zooming (90%∼110%), and randomly horizontally flip, to enlarge the training dataset.
Inference algorithm. In the inference stage, we input a test X-ray image into the trained model and generate a classification score p cls and a scalar anomaly score p ano via the forward propagation. The final decision is made according to
where p avg = (p cls + p ano /margin)/2, T is the threshold that controls the trade-off between sensitivity and specificity.
Experiments

Dataset and Evaluation Metrics
The dataset used for this work includes 100 chest Xray images acquired on 70 subjects, all of which were confirmed with COVID-19, and 1431 chest X-ray images diagnosed as pneumonia (not COVID-19) from 1008 subjects. The COVID-19 cases are available at the Github repository 2 , and the pneumonia cases are available at the ChestX-ray14 dataset [14] .
The screening performance of our model was assessed by the sensitivity, specificity, and area under the receiver operator curve (AUC). Sensitivity and specificity give the proportion of positives and negatives that are correctly identified, respectively, and AUC measures the overall classification performance, which is sensitive to the imbalance between two classes.
Results
We randomly split the data twice and conduct the experiments twice for evaluation. The first split contains 50 images of 33 COVID-19 patients and 714 images of 492 other pneumonia patients for testing and others for training. The second split contains 50 images of 37 COVID-19 patients and 717 images of 516 other pneumonia patients for testing and others for training. The final performance is the average performance on two splits. The parameter T controls the trade-off between the true positive rate (i.e., sensitivity) and true negative rate (i.e., specificity). To investigate the impact of T on the screening performance, we performed the inference stage with different values of T , including 0.50, 0.40, 0.30, 0.25, 0.20 and 0.15. The screening performance obtained by our model was reported in Table 1 and Figure 2 . It shows that
• setting the parameter T to different values in the inference stage leads interestingly to the same AUC value, though the both the sensitivity and specificity are variable; and
• when the parameter T decreases from 0.50 to 0.15, the sensitivity increases from 72.00% to 96.00% and the Specificity drops from 97.97% to 70.65%.
As a model signed for COVID-19 screening, the proposed method aims to reduce the false negative rate as much as possible, since false positive cases can potentially be identified in the subsequent viral nucleic acid detection, but false negative cases will not have a chance for a "second test". Therefore, we suggest setting the parameter T to a small value like 0.15 so as to reduce the false negative rate to as low as 4%.
To demonstrate that our two heads learning is effective, we performed the following two comparisons: (1) single classification network vs. the classification head of our model and (2) single anomaly detection network vs. the anomaly detection head of our model. The ROC curves were plotted in Figure 3 . As we expected, our model, which combines the classification and anomaly detection tasks, outperforms each single task learning model.
We use the Gradient-weighted Class Activation Mapping (Grad-CAM) method [12] to highlight the regions that our model might use to make the predictions. Four patients' chest X-ray images with accompanying Grad-CAMs were shown in Figure 4 . It reveals that our model tends to highlight localized regions within the lungs. 
Discussion and Conclusion
Shi et al. [13] achieved the sensitivity of 90.70% and specificity of 83.30% on a large-scale CT dataset, including 1658 subjects with COVID-19 and 1027 subjects with non-COVID-19 pneumonia. In this study, our model achieves the sensitivity of 90.00% specificity of 87.84% (when T = 0.25) or the sensitivity of 96.00% specificity of 70.65% (when T = 0.15) on the X-ray dataset that contains 100 images from 70 COVID-19 subjects and 1431 images from 1008 non-COVID-19 pneumonia subjects. Compare to the CT-based screening method, our X-ray-based model achieves the comparable performance. More important, our model only learns from 70 COVID-19 subjects, which is less than 5 percent of [13] . Therefore, the proposed model that uses chest X-ray can be considered as an effective computer-aided diagnosis (CAD) tool for low-cost and fast COVID-19 screening. However, our model still has several limitations, such as missing 4% COVID-19 cases and almost 30% of false positive rate. Our future work will focus on further reducing the false negative rate and, if possible, decreasing the false positive rate as well. We will also investigate how to differentiate the COVID-19 severity using chest X-ray and then detect the potentially severe cases for the early treatment, which requires more clinical diagnostic information. What's more, more clinical data are needed to further validate and improve the effectiveness of our model.
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